I congratulate the communities of scientists and patients who participated in the treatment trials to make approved therapy for MASH a reality. Rezdiffra is expected to be available for patients starting in April 2024
Baseline characteristics for both groups are given in Extended Data Table 1
For individuals seeking gradual, science-supported improvements in skin texture, resilience, and visible signs of aging, GHK-Cu may be a valuable addition to a comprehensive skincare strategy
That is what makes NAD+ a systemic lever, a way to support the cellular energy and repair machinery broadly rather than in one isolated spot
It works by increasing insulin production and lowering glucagon secretion, as well as targets areas in the brain that regulate appetite and food intake
This content does not promote or encourage the use of prescription medications for non-approved purposes